The extract significantly attenuated inflammatory mediators and MAPK/NF-κB signaling, while in vivo treatment in a DNCB-induced AD mouse model achieved corticosteroid-comparable anti-inflammatory outcomes without inducing skin atrophy. Here, NFKB1 is linked to Alzheimer disease.